Biomarkers in Heart Disease

James de Lemos, MD, Associate Professor of Medicine J. Fred Schoellkopf, Jr. Chair in Cardiology Research, Director, Coronary Care Unit and Cardiology Fellowship Program, UT Southwestern Medical Center, Dallas, TX, USA.

Part I Biomarkers for the Evaluation of Patients with Ischemic Heart Disease. 1 Protocols for Diagnosing Myocardial Infarction. 2 Troponin and Other Markers of Necrosis for Risk Stratification in Patients with Acute Coronary Syndromes. 3 Challenges Interpreting Cardiac Troponin Values. 4 Natriuretic Peptides and Inflammatory Markers for Risk Stratification in Patients with Ischemic Heart Disease. 5 Novel Markers in Patients with Suspected ACS. Part II Biomarkers for Evaluation of Patients with Heart Failure. 6 Use of Natriuretic Peptides in the Diagnosis of Heart Failure. 7 Biomarkers for Risk Stratification in Patients with Heart Failure. 8 Natriuretic Peptides for Disease Monitoring in Patients with Chronic Heart Failure. Part III Biomarkers for Screening in the Ambulatory Populations. 9 CRP. 10 Newer Markers for Population Screening. Part IV A Look to the Future. 11 Moving Toward Personalized Medicine.